DE60028965D1 - Materialen zur vermehrung von weichgewebe und deren herstellungs- und verwendungsmethoden - Google Patents

Materialen zur vermehrung von weichgewebe und deren herstellungs- und verwendungsmethoden

Info

Publication number
DE60028965D1
DE60028965D1 DE60028965T DE60028965T DE60028965D1 DE 60028965 D1 DE60028965 D1 DE 60028965D1 DE 60028965 T DE60028965 T DE 60028965T DE 60028965 T DE60028965 T DE 60028965T DE 60028965 D1 DE60028965 D1 DE 60028965D1
Authority
DE
Germany
Prior art keywords
materials
cross
reproduction
manufacturing
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60028965T
Other languages
English (en)
Other versions
DE60028965T2 (de
Inventor
Norman Orentreich
A Krajcik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orentreich Foundation for Advancement of Science Inc
Original Assignee
Orentreich Foundation for Advancement of Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orentreich Foundation for Advancement of Science Inc filed Critical Orentreich Foundation for Advancement of Science Inc
Application granted granted Critical
Publication of DE60028965D1 publication Critical patent/DE60028965D1/de
Publication of DE60028965T2 publication Critical patent/DE60028965T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Fiber Materials (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Materials For Medical Uses (AREA)
DE60028965T 1999-05-11 2000-04-13 Materialen zur vermehrung von weichgewebe und deren herstellungs- und verwendungsmethoden Expired - Fee Related DE60028965T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/309,689 US7015198B1 (en) 1999-05-11 1999-05-11 Materials for soft tissue augmentation and methods of making and using same
US309689 1999-05-11
PCT/US2000/010022 WO2000067774A2 (en) 1999-05-11 2000-04-13 Materials for soft tissue augmentation and methods of making and using same

Publications (2)

Publication Number Publication Date
DE60028965D1 true DE60028965D1 (de) 2006-08-03
DE60028965T2 DE60028965T2 (de) 2007-03-29

Family

ID=23199244

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60028965T Expired - Fee Related DE60028965T2 (de) 1999-05-11 2000-04-13 Materialen zur vermehrung von weichgewebe und deren herstellungs- und verwendungsmethoden

Country Status (7)

Country Link
US (1) US7015198B1 (de)
EP (1) EP1178816B1 (de)
AT (1) ATE330621T1 (de)
AU (1) AU4348800A (de)
CA (1) CA2371265A1 (de)
DE (1) DE60028965T2 (de)
WO (1) WO2000067774A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070078435A1 (en) * 2001-06-14 2007-04-05 Corbett Stone Tissue augmentation methods using a medical injection apparatus
WO2003094937A1 (en) * 2002-05-09 2003-11-20 Medigenes A pharmaceutical composition for treatment of wounds containing blood plasma or serum
US20050276863A1 (en) * 2004-05-27 2005-12-15 Medtronic Vascular, Inc. Methods for treatment of aneurysmal tissue
US20070102010A1 (en) * 2005-10-07 2007-05-10 Lemperle Stefan M Naso-pharyngeal tissue engineering
DK2049560T3 (da) 2006-07-13 2013-07-29 Novozymes Biopharma Dk As Fremgangsmåde til fremstilling af partikler af proteinholdigt materiale
WO2009051701A2 (en) * 2007-10-15 2009-04-23 Wake Forest University Health Sciences Methods and compositions for printing biologically compatible nanotube composites of autologous tissue
WO2010028025A1 (en) 2008-09-02 2010-03-11 Gurtner Geoffrey C Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
US9101538B2 (en) 2009-05-20 2015-08-11 Donna M. Tozzi Injectable amino-acid composition
US20100297182A1 (en) * 2009-05-20 2010-11-25 Tozzi Donna M Injectable Amino-acid Composition
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
DK2550027T4 (da) * 2010-03-22 2019-05-13 Allergan Inc Tværbundne polysaccharid- og protein-polysaccharid-hydrogeler til blødvævsforøgelse
WO2012167079A2 (en) 2011-06-03 2012-12-06 Allergan, Inc. Dermal filler compositions including antioxidants
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
ES2527967B1 (es) * 2013-08-01 2015-12-28 Biotechnology Institute, I Mas D, S.L. Formulación de una composición sanguínea rica en plaquetas y/o factores de crecimiento, con proteínas gelificadas y método de preparación de la misma
ES2761558T3 (es) 2014-09-30 2020-05-20 Allergan Ind Sas Composiciones de hidrogel estables que incluyen aditivos

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3152976A (en) 1961-09-21 1964-10-13 Ethicon Inc Preparation of collagenous materials
DE1276650B (de) 1962-05-11 1968-09-05 Iabiotestia Serum Inst G M B H Verfahren zur Herstellung von als Blutplasmaersatzmittel geeigneten, modifizierten Proteinzubereitungen
US4046871A (en) * 1975-04-08 1977-09-06 Ortho Diagnostics Inc. Compositions and serological methods including bovine serum albumin polymers
US4006220A (en) 1975-06-04 1977-02-01 Gottlieb Sheldon K Compositions and methods useful for repairing depressed cutaneous scars
US4404970A (en) 1978-05-19 1983-09-20 Sawyer Philip Nicholas Hemostatic article and methods for preparing and employing the same
US5628781A (en) 1985-06-06 1997-05-13 Thomas Jefferson University Implant materials, methods of treating the surface of implants with microvascular endothelial cells, and the treated implants themselves
US5147514A (en) 1987-08-02 1992-09-15 University Of North Carolina Process for cross-linking collagenous material and resulting product
US4969912A (en) 1988-02-18 1990-11-13 Kelman Charles D Human collagen processing and autoimplant use
US5162430A (en) 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
US5550187A (en) 1988-11-21 1996-08-27 Collagen Corporation Method of preparing crosslinked biomaterial compositions for use in tissue augmentation
US5527856A (en) 1988-11-21 1996-06-18 Collagen Corporation Method of preparing crosslinked biomaterial compositions for use in tissue augmentation
AT398276B (de) 1989-05-31 1994-11-25 Sorin Biomedica Spa Verfahren zur präparierung von biologischem implantationsmaterial
AU4693093A (en) 1992-07-27 1994-02-14 Haemacure Biotech Inc. Biocompatible surgical implant
CN1091315A (zh) 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法
US5733545A (en) 1995-03-03 1998-03-31 Quantic Biomedical Partners Platelet glue wound sealant
US6020181A (en) * 1995-05-17 2000-02-01 New York Blood, Inc. Inhibition of thrombus formation by medical related apparatus comprising treating with fibrinolytic matrix metalloproteinase

Also Published As

Publication number Publication date
EP1178816B1 (de) 2006-06-21
DE60028965T2 (de) 2007-03-29
ATE330621T1 (de) 2006-07-15
EP1178816A2 (de) 2002-02-13
AU4348800A (en) 2000-11-21
WO2000067774A3 (en) 2001-02-08
US7015198B1 (en) 2006-03-21
CA2371265A1 (en) 2000-11-16
WO2000067774A2 (en) 2000-11-16

Similar Documents

Publication Publication Date Title
DE60028965D1 (de) Materialen zur vermehrung von weichgewebe und deren herstellungs- und verwendungsmethoden
AU618834B2 (en) Synthetic amino acid and/or peptide-containing graft copolymers
ATE250399T1 (de) Gebrauch von autologen, dermalen fibroblasten zur reperatur von haut- oder weichgewebeschäden
NO931809D0 (no) Hemofilter
AU573626B2 (en) Protein/polysaccharide complexes as wound dressing
CN105616184B (zh) 一种透明质酸多肽键合物面膜及其制备方法
ATE368054T1 (de) Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität
NZ337845A (en) Non-antigenic branched polymer conjugates
DE69801517T2 (de) Verfahren zur verhinderung der verkalkung von aldehyd-fixierten bioprothesenmaterialien
ATE321141T1 (de) Verfahren zur herstellung eines rekombinanten polypeptids unter hinzufügung eines chymotrypsinhemmstoffes zum zellkulturmedium
Spira et al. Human amnion collagen for soft tissue augmentation—biochemical characterizations and animal observations
Kim et al. Evaluation of an amniotic membrane-collagen dermal substitute in the management of full-thickness skin defects in a pig
NO971341L (no) Promoter for reseptor tyrosinkinase TIE
ATE255915T1 (de) Dermales gerüst auf der grundlage eines neutralisierten chitosan-schwammes oder eines neutralsierten gemischten chitosan-kollagen- schwammes
Lin et al. Studies of novel hyaluronic acid-collagen sponge materials composed of two different species of type I collagen
DE69029969D1 (de) Kunsthaut
ATE202557T1 (de) 15-fluoro-prostaglandine als augendrucksenkende mittel
DE60135291D1 (de) Verfahren zur Herstellung von Naturkautschuklatex mit geringer allergischer Wirkung und von deproteinisiertem Naturkautschuklatex und Naturkautschuklatex mit geringer allergischer Wirkung und deproteinisierter Naturkautschuklatex
Aoki et al. Demonstration of tissue-specific soluble antigens in human skin by immunodiffusion
ATE286509T1 (de) Interferon alpha/beta bindendes protein, seine herstellung und anwendung
EP1849800A3 (de) Moraxella catarrhalis-Proteine
JPS62145006A (ja) 化学的に修飾されたコラ−ゲンによりなる化粧用フイルム
CA2086835A1 (en) Tissue plasminogen activator variants with decreased clearance
DE60024977D1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen
CN113244450A (zh) 一种用于手部抗衰的活性填充剂及其制备方法

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee